Last reviewed · How we verify

NCT06203886: LumbaCure2303

Effect of the LumbaCure® Intervention on Elderly Patients Suffering From cLBP.

Completed NA Last updated 29 August 2024
What this trial tests

NA trial testing LumbaCure in Low Back Pain in 10 participants. Completed in 18 July 2024.

Timeline
11 December 2023
Primary endpoint
17 June 2024
18 July 2024

Quick facts

Lead sponsorOdix
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date11 December 2023
Primary completion17 June 2024
Estimated completion18 July 2024
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Odix

Who can join

60 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this investigation is to evaluate the safety and efficacy of the LumbaCure® device in elderly people suffering from low back pain. The study is being carried out at several sites, in nursing homes, in order to reach the elderly patients most at risk of a sedentary lifestyle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Odix trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06203886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing